DETECTION OF BACTERIAL ENDOTOXINS IN DRUGS: DISTURBING FACTORS AND THEIR ELIMINATION

DOI: https://doi.org/None
Issue: 
6
Year: 
2017

O.V. Shapovalova; N.P. Neugodova, PhD; G.A. Sapozhnikova; A.A. Agashirinova; O.V. Gunar, PhD Research Center for Examination of Medical Products, Ministry of Health of the Russian Federation; 8, Petrovsky Boulevard, Build. 2, Moscow 127051, Russian Federation

Introduction. It is important to ensure the absence of pyrogenic impurities in the manufacture of parenteral drugs. Control of pharmaceutical substances for bacterial endotoxins is a complex problem with the substances that are poorly water-soluble and/or have obstacles in carrying out the LAL test. Objective: to investigate the influence of the factors that may interfere with the detection of bacterial endotoxins via the gel-clot test, to search, and choose a method that eliminates the disturbing factors. Material and methods. The investigation objects were pharmaceutical substances, such as ascorbic acid and Teraftal, and blood drugs. The LAL-test in the modification of the gel-clot used tris-buffer (Tris-hydroxyethylaminomethyl hydrochloride), magnesium chloride solution, and the specific buffer β-glycan blocker. Results. Procedures were proposed to eliminate the factors interfering with the LAL-test. The most common causes of false results, such as inhibited gel formation due to a wrong pH value or the ability of substances to form complexes, were considered. A decision was proposed to prevent false-positive results in the index “Bacterial endotoxins” in experiments with blood preparations. Conclusion. Approaches to eliminating the influence of disturbing factors on the results of the LAL-test were elaborated.

Keywords: 
drugs
pharmaceutical substances
quality
bacterial endotoxins
LAL test
false results
disturbing factors
inhibition
potentiation

References: 
  1. Shapovalova O.V., Dolgova G.V., Neugodova N.P., Sapozhnikova G.A. Ispol`zovanie organicheskih rastvoriteley dlya opredeleniya pokazatelya «Bakterial`nye e`ndotoksiny» v farmacevticheskih substanciyah, ne rastvorimyh v vode. Antibiotiki i himioterapiya, 2013; 58: 41–4.
  2. Shapovalova O.V., Neugodova N.P., Dolgova G.V., Sapozhnikova G.A. Osobennosti provedeniya razrabotki razdela «Bakterial`nye e`ndotoksiny» dlya substanciy antibiotikov. Antibiotiki i himioterapiya, 2008; 53: 34–8.
  3. Merkulova Yu.V., Dolgova G.V., Chayka L.A., Gomon O.N., Neugodova N.P., Shapovalova O.V. Osobennosti provedeniya ispytaniya na bakterial`nye e`ndotoksiny lekarstvennyh sredstv v vide maslyanyh rastvorov. Farmakom, 2008; 1: 67–73.
  4. Shapovalova O.V., Neugodova N.P., Dolgova G.V., Sapozhnikova G.A. Metodicheskie podhody k razrabotke pokazatelya «Bakterial`nye e`ndotoksiny» v farmacevticheskih substanciyah. Vedomosti Nauchnogo centra e`kspertizy sredstv medicinskogo primeneniya. 2012; 3: 47–50.
  5. Merkulova Yu.V., Chayka L.A., Gomon O.N. Ispol`zovanie bufernyh rastvorov v ispytanii «Bakterial`nye e`ndotoksiny». Farmakom, 2009; 3: 40–8.
  6. Nagarajan K., Chakraborty Shibu, Chitnis P. K. Inhibition and Enhancement. BET Newsletter A Charles River Private Limited Communication, 2010; 1 (4): 5.
  7. Low Endotoxin Recovery (LER): A Review. LALUpdate, 2014; 30 (2): 8.
  8. Sitnikov A.G., Travina L.A., Bagirova V.L. LAL-test. Sovremennye podhody k opredeleniyu pirogennosti. M., 1997; 27–8.
  9. Hurley, J.C., F.A. Tosolini, W.J. Louis. Quantitative Limulus lysate assay for endotoxin and the effect of plasma. Clin. Pathol, 1991; 44(10): 849–54.
  10. Nagarajan K., Chitnis P. K. Part II: Enhancement». BET Newsletter A Charles River Private Limited Communication, 2010; 1 (5): 5.
  11. Gosudarstvennaya farmakopeya Rossiyskoy Federacii XII izd. ch. I. FS 42-0218-07 «Askorbinovaya kislota». M: Nauchnyy centr e`kspertizy sredstv medicinskogo primeneniya, 2007.
  12. Gosudarstvennaya farmakopeya Rossiyskoy Federacii XIII izd. [E`lektronnyy resurs]. Rezhim dostupa: http://pharmacopoeia.ru/ofs-1-2-4-0006-15-bakterialnye-endotoksiny